KKR and Flerie Form Specialized Pharma Services Platform Frontier Biosolutions and Invest in Coriolis Pharma, Co-investor Thomas Eldered to Serve as Frontier's Executive Chairman
Portfolio Pulse from Benzinga Newsdesk
Investment firm KKR and Flerie have partnered to form a new global pharma services platform, Frontier Biosolutions. Frontier will invest in companies focused on specialized pharmaceutical services to advanced therapeutics customers. Thomas Eldered, co-founder of Recipharm and a life sciences investor at Flerie, will serve as Frontier's Executive Chairman.
October 16, 2023 | 7:22 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
KKR's partnership with Flerie to form Frontier Biosolutions could potentially expand its portfolio and increase its influence in the pharmaceutical sector.
The formation of Frontier Biosolutions represents a strategic move for KKR to invest in the pharmaceutical sector. This could potentially lead to an expansion of its portfolio and increase its influence in the sector. Given KKR's significant role in this partnership, the news is highly relevant and important for its investors.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100